Unique Mass Spectrometer for Analysis of Semiconductor Process Gases

June 15, 2017, Peabody, Mass. — The JEOL InfiTOF compact high-resolution gas analysis mass spectrometer is ideal for monitoring trace impurities in semiconductor process gases, evolved gases from catalytic reactions, vapor epitaxy and more.  No larger than a desktop PC, the InfiTOF instantly separates isobaric gases such CO and N2, or N2O and CO2, for... Read more

MTS Systems Awards Endowment to Michigan Technological University in Honor of PCB Founders Jim and Bob Lally

EDEN PRAIRIE, MN, June 13, 2017 /PRNewswire/ — MTS Systems Corporation (NASDAQ: MTSC), a leading global supplier of high-performance test and measurement systems and sensors, today announced establishment of the ‘James and Robert Lally Endowment’ at Michigan Technological University.  This $1 million endowment was given in honor of the pioneering efforts of the Lallys in the... Read more

Collaboration Between Shimadzu, The Systems Biology Institute, and Osaka University Starting the Provision of an Open Platform Multi-omics Data Analysis Pack

Research for creating substances with advanced functions utilizing microorganisms and cells, rather than chemical synthesis, has expanded in recent years in a variety of fields, including biofuels, pharmaceuticals, and food products for example. Advancement in gene editing techniques is further creating new avenues of research. In this direction of research, the effect of incorporating genes... Read more

FDA approves Roche’s Actemra/RoActemra (tocilizumab) for giant cell arteritis

Basel, 23 May 2017 FDA approves Roche’s Actemra/RoActemra (tocilizumab) for giant cell arteritis Actemra/RoActemra is the first FDA-approved treatment for adults with giant cell arteritis (GCA) FDA previously granted Priority Review and Breakthrough Therapy Designation for Actemra/RoActemra in GCA Sixth FDA approval for Actemra/RoActemra since its US launch in 2010 Roche (SIX: RO, ROG; OTCQX:... Read more

FDA approves Roche’s Actemra/RoActemra (tocilizumab) for giant cell arteritis

Basel, 23 May 2017 FDA approves Roche’s Actemra/RoActemra (tocilizumab) for giant cell arteritis Actemra/RoActemra is the first FDA-approved treatment for adults with giant cell arteritis (GCA) FDA previously granted Priority Review and Breakthrough Therapy Designation for Actemra/RoActemra in GCA Sixth FDA approval for Actemra/RoActemra since its US launch in 2010 Roche (SIX: RO, ROG; OTCQX:... Read more

Bruker Launches the S8 TIGER™ Series 2 WDXRF System for Elemental Analysis in Industrial and Academic Research and Materials Quality Control

KARLSRUHE, Germany, May 22, 2017 /PRNewswire/ — Today Bruker announces the launch of its new S8 TIGER™ Series 2, the next-generation Wavelength Dispersive X-Ray Fluorescence (WDXRF) spectrometer. The S8 TIGER Series 2 is the most versatile WDXRF tool available for advanced quantitative elemental analysis in industrial and academic materials research, as well as in industrial quality... Read more

Top-of-the-Line Gas Chromatograph Offers the Highest Level of Core Performance in the World and an Advanced User Interface that Provides Excellent Operability and Easy Maintenance Release of Nexis GC-2030

Gas chromatographs are used for R&D and quality control in a wide range of fields, such as petrochemicals, fine chemicals, environmental testing, pharmaceuticals, food products, electronics/semiconductors, and flavorings. With the growing concern about safety and to minimize any impact on both humans and the environment, there is increasing demand for analyzing trace impurities in raw... Read more

AMETEK Develops FlarePro Mass Spectrometer for Flare Gas Combustion Monitoring

Monday, May 8, 2017 JOIN THE CONVERSATION Contact: Anthony Slapikas, (412) 826-2452, tony.slapikas@ametek.com AMETEK Develops FlarePro Mass Spectrometer for Flare Gas Combustion Monitoring Accurately and Reliably Determines Flare Gas Heating Values PITTSBURGH, PA—New rules for flare stack combustion from the US Environmental Protection Agency (EPA) set to take effect in early 2019 include additional monitoring and... Read more